Interior Health Authority: Discharge Summary Template

DATE OF ADMISSION: 15/10/2024 DATE OF DISCHARGE: 01/11/2024 MOST RESPONSIBLE DIAGNOSIS PNEUMONIA: Onset 10/10/2024. Patient presented with cough, fever, and shortness of breath. Chest X-ray confirmed right lower lobe pneumonia. Treated with intravenous antibiotics and supportive care. Patient responded well to treatment. RELEVANT PRE-ADMIT DIAGNOSES/CONDITIONS 1. Hypertension: Diagnosed 2018, managed with Lisinopril 20mg daily. 2. Type 2 Diabetes Mellitus: Diagnosed 2020, managed with Metformin 1000mg twice daily. 3. Hyperlipidemia: Diagnosed 2019, managed with Atorvastatin 40mg daily. PAST MEDICAL HISTORY * Cholecystectomy (2015) * Appendectomy (2010) OPERATIVE AND OTHER INTERVENTIONS IN HOSPITAL 1. 16/10/2024: Chest X-ray 2. 17/10/2024: Blood cultures drawn 3. 18/10/2024: Intravenous antibiotics initiated COURSE IN HOSPITAL & CONDITION ON DISCHARGE PNEUMONIA: Patient was admitted with right lower lobe pneumonia. Initial presentation included cough, fever, and shortness of breath. Chest X-ray confirmed the diagnosis. The patient was started on intravenous antibiotics (Ceftriaxone) and supportive care, including oxygen therapy. The patient's condition improved with treatment, and the fever subsided. The patient was transitioned to oral antibiotics (Amoxicillin) on 28/10/2024. DIABETES: Blood sugars were monitored closely during the hospital stay. Metformin was continued, and insulin was added to manage hyperglycemia. The patient's blood sugars were well-controlled before discharge. HYPERTENSION: The patient's blood pressure was monitored and well-controlled with Lisinopril. HEART FAILURE: The patient's heart failure was stable during the hospital stay. On discharge, the patient was afebrile, with improved respiratory function. The patient was able to ambulate independently and was tolerating a regular diet. The patient was discharged home with instructions for follow-up. "Additional discharge instructions are noted below." "Documentation generated with AI scribe. Content was reviewed by myself. Patient was not recorded in transcript. I am compliant with IHA AI Scribe policy." MEDICATIONS Changed: 1. Ceftriaxone 1g IV q24h (stopped on 28/10/2024) 2. Insulin (added during admission, dosage and frequency as per blood glucose levels) Continued: 1. Lisinopril 20mg daily 2. Metformin 1000mg twice daily 3. Atorvastatin 40mg daily Stopped: 1. Amoxicillin 500mg PO BID (stopped on 01/11/2024) New Started: 1. Amoxicillin 500mg PO BID (started on 28/10/2024) DISCHARGE LOCATION Home DISCHARGE INSTRUCTIONS & ADVICE * Follow-up appointment with primary care physician in 7 days. * Continue current medications as prescribed. * Monitor for signs of recurrent infection (fever, cough, shortness of breath). * Outpatient lab work: CBC, CMP in 1 week. Allergies: Penicillin Other Forms Completed: None